16818699

Source:http://linkedlifedata.com/resource/pubmed/id/16818699

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0009264, umls-concept:C0012984, umls-concept:C0023828, umls-concept:C0027651, umls-concept:C0205359, umls-concept:C0332324, umls-concept:C0920321
pubmed:issue	13
pubmed:dateCreated	2006-7-4
pubmed:abstractText	To determine the maximum tolerated dose, dose-limiting toxicities, and pharmacokinetic characteristics of doxorubicin encapsulated in a low temperature sensitive liposome (LTSL) when given concurrently with local hyperthermia to canine solid tumors.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/P01CA42745
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Liposomes
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1078-0432
pubmed:author	pubmed-author:DewhirstMark WMW, pubmed-author:HauckMarlene LML, pubmed-author:KleinAllisonA, pubmed-author:LaRueSusan MSM, pubmed-author:NeedhamDavidD, pubmed-author:PetrosWilliam PWP, pubmed-author:PoulsonJean MJM, pubmed-author:PruittAmy FAF, pubmed-author:RauM TMT, pubmed-author:SpasojevicIvanI, pubmed-author:ThrallDonald EDE, pubmed-author:YuDaohaiD
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	4004-10
pubmed:meshHeading	pubmed-meshheading:16818699-Animals, pubmed-meshheading:16818699-Antineoplastic Agents, pubmed-meshheading:16818699-Carcinoma, pubmed-meshheading:16818699-Combined Modality Therapy, pubmed-meshheading:16818699-Dog Diseases, pubmed-meshheading:16818699-Dogs, pubmed-meshheading:16818699-Dose-Response Relationship, Drug, pubmed-meshheading:16818699-Doxorubicin, pubmed-meshheading:16818699-Drug Administration Schedule, pubmed-meshheading:16818699-Drug Delivery Systems, pubmed-meshheading:16818699-Female, pubmed-meshheading:16818699-Hyperthermia, Induced, pubmed-meshheading:16818699-Liposomes, pubmed-meshheading:16818699-Male, pubmed-meshheading:16818699-Maximum Tolerated Dose, pubmed-meshheading:16818699-Microwaves, pubmed-meshheading:16818699-Sarcoma, pubmed-meshheading:16818699-Temperature, pubmed-meshheading:16818699-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors.
pubmed:affiliation	Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina 27606, USA. marlene_hauck@ncsu.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I, Research Support, N.I.H., Extramural